One FTSE 250 dividend stock I’d sell to buy this surging growth star

This FTSE 250 (INDEXFTSE: MCX) stock looks to be struggling and there’s at least one better buy out there.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Everyman Media (LSE: EMAN) claims that it is “redefining cinema” by offering customers a more bespoke and comfortable experience than that provided by peers such as Cineworld (LSE: CINE). 

The strategy seems to be working. Today the company reported that for the 52 weeks to the end of December, revenue grew 37% to £40.6m, and cinema admissions expanded 32% to 2.2m. 

It appears the bulk of this growth was at existing premises. Specifically, today’s release notes that just two Everyman venues opened during 2017, expanding the portfolio by 10% to 22 sites. The company also undertook some significant renovations of its existing portfolio throughout the year, including adding to new screens to its Muswell Hill and Oxted venues.

A premium offering

Everyman’s strength is its premium offering, which consumers are more than happy to pay for according to the firm’s figures. Last year the company recorded an average box office ticket price of £11.28, and average food and beverage spend per head of £5.97. These figures are more than double those reported by Cineworld. For the period to the end of June 2017, Cineworld achieved an average ticket price per head of £5.27 and an average retail spend per person of £2.04.

That said, nine of Everyman’s 22 screens, or 40% of the current portfolio, are based in London where prices are higher than the rest of the UK, but so are operating costs. Still, Everyman is more profitable than Cineworld overall with a gross profit margin of 60% compared to Cineworld’s 26%.

And when it comes to growth, the young upstart has an edge over its older, more established peer.

Set for growth

Everyman exchanged contracts on nine news sites during 2017 funded through an equity raise of £17m in October. Another deal was completed in January of 2018 when the firm exchange contracts on a freehold site in Crystal Palace, London for £3.3m. (With only £7m of debt on the balance sheet at year-end, and a net cash balance of £11.4m, I wouldn’t rule out more of these deals in 2018.) 

As these new venues begin to open, City analysts believe net profit could grow by as much as 40% in 2018 and earnings per share could hit 4.9p. Based on these numbers the shares are trading at a forward P/E ratio of 39.4, which looks expensive, but when you consider the company’s cash-rich balance sheet and rapid growth rate, it is clear the business deserves a high multiple.

Meanwhile, following the acquisition of US cinema group Regal, (completed in February) City analysts are expecting Cineworld’s revenue to jump 225% in 2018, and net profit is expected to double. However, because the company relied on a rights issue to finance part of the deal, earnings per share are only expected to grow by 22% thanks to the dilution.

Further, the group is drowning in debt following the merger, with analysts estimating that net debt to earnings before interest, taxes, depreciation and amortisation will be 4 times this year, leaving management little room for manoeuvre if things don’t go to plan.

Considering all of the above, even though shares in Cineworld look cheaper than Everman (the shares are trading at a forward P/E of 12 and support a dividend yield of 4.4%) I’d stay away from the group. Everyman appears to offer a better all-round proposition for investors. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

1 stock set to gatecrash the FTSE 100 in 2025!

Our writer considers a quality stock that's poised to join the FTSE 100 next year. Could there also be a…

Read more »

Businesswoman calculating finances in an office
Investing Articles

As earnings growth boosts the Imperial Brands share price, is it a top FTSE 100 dividend choice?

The Imperial Brands share price has come storming back as investors piled in for the big dividends. What's next, after…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
US Stock

Warren Buffett just bought and sold these stocks. Here’s why I don’t agree

Jon Smith takes a look at the recent regulatory filing for Berkshire Hathaway and Warren Buffett and comments on recent…

Read more »

US Stock

My favourite US growth stock’s up 33% this year. I think it’s just getting started

Edward Sheldon's taken a large position in this well-known S&P 500 growth stock. And so far, it’s working very well…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The Diploma share price falls 7% as revenues and profits keep growing. Time to buy?

As Diploma continues its impressive growth, its share price is faltering. Stephen Wright takes a closer look at one of…

Read more »

Growth Shares

Directors at this FTSE 100 company just bought over £2m worth of shares

Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Down 24%! As the Glencore share price falls like snow, is it finally time to let it go?

Harvey Jones thought the Glencore share price was in bargain territory when he bought the FTSE 100 commodity giant last…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

591 shares in this FTSE 100 high-yield gem could make me £14,873 a year in passive income over time!

A big passive income can be generated from much smaller investments earlier in life, especially if the dividend returns are…

Read more »